Screening for chlamydia and/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences

DiscussionMost of the evidence on screening for CT and/or NG offers low or very low certainty about the benefits and harms. Indirectness from use of comparison groups receiving some screening, incomplete outcome ascertainment, and use of outreach settings was a major contributor to uncertainty. Patient preferences indicate that the potential benefits from screening appear to outweigh the possible harms. Direct evidence about which screening strategies and intervals to use, which age to start and stop screening, and whether screening males in addition to females is necessary to prevent clinical outcomes is scarce, and further research in these areas would be informative. Apart from the evidence in this review, information on factors related to equity, acceptability, implementation, cost/resources, and feasibility will support recommendations made by the Task Force.Systematic review registrationInternational Prospective Register of Systematic Reviews (PROSPERO), registration numberCRD42018100733.
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research